| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. | Neurobiol Aging | 2013 | 0.93 |
| 2 | Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. | Anesth Analg | 2012 | 0.89 |
| 3 | Activation of the CB2 receptor system reverses amyloid-induced memory deficiency. | Neurobiol Aging | 2012 | 0.87 |
| 4 | In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7. | J Pharm Sci | 2012 | 0.75 |